Valvular (18)F-Fluoride and (18)F-Fluorodeoxyglucose Uptake Predict Disease Progression and Clinical Outcome in Patients With Aortic Stenosis.
William S A
WS
Jenkins
Alex T
AT
Vesey
Anoop S V
AS
Shah
Tania A
TA
Pawade
Calvin W L
CW
Chin
Audrey C
AC
White
Alison
A
Fletcher
Timothy R G
TR
Cartlidge
Andrew J
AJ
Mitchell
Mark A H
MA
Pringle
Oliver S
OS
Brown
Renzo
R
Pessotto
Graham
G
McKillop
Edwin J R
EJ
Van Beek
Nicholas A
NA
Boon
James H F
JH
Rudd
David E
DE
Newby
Marc R
MR
Dweck
D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve / Q000000981:diagnostic imaging / Q000187:drug effects; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000000981:diagnostic imaging*; D016022:Case-Control Studies; D018450:Disease Progression; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics* / Q000494:pharmacology; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D012969:Sodium Fluoride / Q000493:pharmacokinetics*; D014057:Tomography, X-Ray Computed / Q000379:methods
D019788:Fluorodeoxyglucose F18; D012969:Sodium Fluoride